Insulinoma: Spectrum of Clinicopathological Features in a Tertiary Center/Insulinoma: Ucuncul Bir Merkezdeki Klinikopatolojik Ozelliklerin Spektrumu

Introduction: Insulinoma is the most common functional neuroendocrine tumor of the pancreas. There are different methods for the preoperative localization of insulinoma, such as Computed Tomography (CT) scan, Magnetic Resonance Imaging and Endoscopic Ultra Sonography (EUS). In this study, we report...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:İstanbul Medical Journal 2021-02, Vol.22 (1), p.61
Hauptverfasser: Shirzad, Nooshin, Ahmadi, Pooria, Shahsiah, Reza, Hemmatabadi, Mahboobeh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction: Insulinoma is the most common functional neuroendocrine tumor of the pancreas. There are different methods for the preoperative localization of insulinoma, such as Computed Tomography (CT) scan, Magnetic Resonance Imaging and Endoscopic Ultra Sonography (EUS). In this study, we report on the clinicopathological features of insulinoma in 43 patients. Methods: The hospital records of 43 patients with suspicion of insulinoma based on biochemical diagnostic criteria, referred to Imam Khomeini Complex Hospital, Tehran, Iran between 2006 and 2016, were reviewed retrospectively. Results: Of the 43 studied patients, 28 were female. The mean age of the patients was 45.4[+ or -]13.3 years. The most frequent clinical presentation of insulinoma was neurogenic and neuroglycopenic symptoms (81.4%). Mean glucose, insulin, and C-peptide in patients with hypoglycemic crisis were 39.13[+ or -]13.15 mg/dL, 32.15[+ or -]32.53 qUI/mL, and 4.77[+ or -]2.88 ng/mL, respectively. Mean tumor size was 2.13[+ or -]1.22 cm. The most common site of insulinoma was the tail of the pancreas. Surgery was the treatment of choice and performed in 31 patients. Of 21 tumors studied microscopically, 7 were invasive. Conclusion: In non-diabetic patients with manifestations of hypoglycemia, a diagnosis of insulinoma should be considered. During the past decade, the diagnostic delay for insulinoma has been reduced in our country by improving imaging technologies. EUS and CT scan are the best modalities for localization and size measurement of insulinoma. Tumor size has decreased compared with previous decades, probably due to a reduced delay in diagnosis. Keywords: Insulinoma, hypoglycemia, neoplasm, pancreas Amac: Insulinoma pankreasin en sik gorulen fonksiyonel noroendokrin tumorudur. Bilgisayarli Tomografi (BT) tarama, Manyetik Rezonans Goruntuleme ve Endoskopik Ultrasonografi (EUS) gibi insulinomalarin preoperatif lokalizasyonu icin farkli yontemler vardir. Bu calismada 43 hastada insulinomun klinikopatolojik ozellikleri sunulmaktadir. Yontemler: 2006-2016 yillari arasinda Tahran, Iran'da Imam Humeyni Kompleks Hastanesi'ne atifta bulunulan biyokimyasal tani kriterlerine gore insulinoma suphesi olan 43 hastanin retrospektif olarak hastane kayitlari incelendi. Bulgular: Calisilan 43 hastanin 28'i kadindi. Hastalarin ortalama yasi 45,4[+ or -]13,3 idi. Insulinomun en klinik gorunumu norojenik ve noroglikopenik semptomlardi (%81,4). Hipoglisemik kriz hastalarinda ortalama glikoz, ins
ISSN:2619-9793
DOI:10.4274/imj.galenos.2021.45202